Star Pacific Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Star Pacific Tbk trades at Rp250 (market cap 278.56B, 813.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Star Pacific Tbk is the larger of the two by market cap, and Star Pacific Tbk is more actively traded (813.5K versus 96.7K). Which is the better fit depends on your goals.
| LPLI | OBAT | |
|---|---|---|
Market Cap | 278.56B | 167.37B |
Volume | 813.5K | 96.7K |
Lot | 8.14K | 967 |
Turnover | 204.32M | 23.82M |
Average Price | 251.17 | 246.34 |
Value | 204.32M | 23.82M |
Indicative Equilibrium Price | 250 | 248 |
Indicative Equilibrium Volume | 70 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Read more on LPLI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →